Inventiva (IVA) Depreciation & Amortization (CF) (2022 - 2025)

Inventiva (IVA) recorded quarterly Depreciation & Amortization (CF) of -$19.0 million in Q2 2025, down 17.2% quarter-over-quarter from -$16.2 million in Q4 2024, and down 42.54% on a YoY basis from -$33.1 million in Q2 2024.

Inventiva (IVA) Depreciation & Amortization (CF) (2022 - 2025) Analysis & Trends

Inventiva's Depreciation & Amortization (CF) history runs 4 years deep, the most recent figure standing at -$19.0 million for Q2 2025.

  • In Q2 2025, Depreciation & Amortization (CF) fell 42.54% year-over-year to -$19.0 million; the TTM figure through Jun 2025 stood at -$19.0 million (down 42.54% YoY), while the FY2024 annual figure was -$16.2 million, down 40.84% from the prior year.
  • Depreciation & Amortization (CF) was -$19.0 million for Q2 2025 at Inventiva, down from -$16.2 million in the prior quarter.
  • In the past five years, Depreciation & Amortization (CF) ranged from a high of -$8.7 million in Q4 2022 to a low of -$19.0 million in Q2 2025.
  • Historically, Depreciation & Amortization (CF) has averaged -$13.2 million across 4 years, with a median of -$12.4 million in 2024.
  • The sharpest annual moves came in 2024 and 2025: Depreciation & Amortization (CF) retreated 29.29% in 2024, then slumped 42.54% in 2025.
  • A 4-year view of Depreciation & Amortization (CF) shows it stood at -$8.7 million in 2022, then sank by 32.07% to -$11.5 million in 2023, then sank by 40.84% to -$16.2 million in 2024, then dropped by 17.2% to -$19.0 million in 2025.
  • The last three Depreciation & Amortization (CF) figures came in at -$19.0 million (Q2 2025), -$16.2 million (Q4 2024), and -$13.3 million (Q2 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation & Amortization (Qtr)
1 Alterity Therapeutics 814,307.08 Bn 814,307.05 Bn - 1,395.22
2 Belite Bio 55,320.00 Bn 55,320.00 Bn - -
3 Quantum Biopharma 17,149.72 Bn 17,149.72 Bn - -
4 Legend Biotech 3,590.00 Bn 3,589.71 Bn 242.10 Mn -
5 Akari Therapeutics 1,650.72 Bn 1,650.72 Bn - -
6 Evaxion A 1,522.09 Bn 1,522.07 Bn - -
7 Psyence Biomedical 229.39 Bn 229.38 Bn - -1,330.00
8 Vertex Pharmaceuticals 113.09 Bn 105.85 Bn 2.59 Bn 55.90 Mn
9 Abivax 90.15 Bn 90.15 Bn - 429,663.65
10 Inventiva 8.64 Mn -260.09 Mn - -

Historic Data

Download Data
DateValue
Jun 30, 2025 -19.03 Mn
Jun 30, 2025 -19.03 Mn
Dec 31, 2024 -16.24 Mn
Dec 31, 2024 -16.24 Mn
Jun 30, 2024 -13.35 Mn
Jun 30, 2024 -13.35 Mn
Dec 31, 2023 -11.53 Mn
Dec 31, 2023 -11.53 Mn
Jun 30, 2023 -10.33 Mn
Jun 30, 2023 -10.33 Mn
Dec 31, 2022 -8.73 Mn
Dec 31, 2022 -8.73 Mn